Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.99
Delayed Data
As of Feb 27
 -0.19 / -2.07%
Today’s Change
7.09
Today|||52-Week Range
11.47
+8.31%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +27.92% increase from the last price of 8.99.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$26.2M
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -109.93%
 
 
 
 
 
 
Growthannually 107.85%
 
 
 
 
 

Sales

Growthquarterly -49.99%
 
 
 
 
 
 
Growthannually 878.00%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account